| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |